Works by Heinzer, Hans


Results: 74
    1
    2
    3

    Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

    Published in:
    BJU International, 2007, v. 99, n. 6, p. 1404, doi. 10.1111/j.1464-410X.2007.06771.x
    By:
    • Gallina, Andrea;
    • Karakiewicz, Pierre I.;
    • Chun, Felix K.-H.;
    • Briganti, Alberto;
    • Graefen, Markus;
    • Montorsi, Francesco;
    • Walz, Jochen;
    • Jeldres, Claudio;
    • Erbersdobler, Andreas;
    • Salonia, Andrea;
    • Suardi, Nazareno;
    • Deh, Federico;
    • Schlomm, Thorsten;
    • Scattoni, Vincenzo;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Valiquette, Luc;
    • Rigatti, Patrizio;
    • Huland, Hartwig
    Publication type:
    Article
    4

    Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.

    Published in:
    BJU International, 2006, v. 98, n. 6, p. 1204, doi. 10.1111/j.1464-410X.2006.06442.x
    By:
    • Chun, Felix K.-H.;
    • Briganti, Alberto;
    • Antebi, Elie;
    • Graefen, Markus;
    • Currlin, Eike;
    • Steuber, Thomas;
    • Schlomm, Thorsten;
    • Walz, Jochen;
    • Haese, Alexander;
    • Friedrich, Martin G.;
    • Ahyai, Sascha A.;
    • Eichelberg, Christian;
    • Salomon, Georg;
    • Gallina, Andrea;
    • Erbersdobler, Andreas;
    • Perrotte, Paul;
    • Heinzer, Hans;
    • Huland, Hartwig;
    • Karakiewicz, Pierre I.
    Publication type:
    Article
    5

    Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.

    Published in:
    BJU International, 2006, v. 98, n. 2, p. 329, doi. 10.1111/j.1464-410X.2006.06262.x
    By:
    • Chun, Felix K.-H.;
    • Briganti, Alberto;
    • Shariat, Shahrokh F.;
    • Graefen, Markus;
    • Montorsi, Francesco;
    • Erbersdobler, Andreas;
    • Steuber, Thomas;
    • Salonia, Andrea;
    • Currlin, Eike;
    • Scattoni, Vincenzo;
    • Friedrich, Martin G.;
    • Schlomm, Thorsten;
    • Haese, Alexander;
    • Michl, Uwe;
    • Colombo, Renzo;
    • Heinzer, Hans;
    • Valiquette, Luc;
    • Rigatti, Patrizio;
    • Roehrborn, Claus G.;
    • Huland, Hartwig
    Publication type:
    Article
    6

    Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 1, p. 129, doi. 10.1002/1878-0261.12597
    By:
    • Höflmayer, Doris;
    • Steinhoff, Amélie;
    • Hube‐Magg, Claudia;
    • Kluth, Martina;
    • Simon, Ronald;
    • Burandt, Eike;
    • Tsourlakis, Maria Christina;
    • Minner, Sarah;
    • Sauter, Guido;
    • Büscheck, Franziska;
    • Wilczak, Waldemar;
    • Steurer, Stefan;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Schlomm, Thorsten;
    • Jacobsen, Frank;
    • Hinsch, Andrea;
    • Poos, Alexandra M.
    Publication type:
    Article
    7

    High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.

    Published in:
    Molecular Oncology, 2013, v. 7, n. 6, p. 1001, doi. 10.1016/j.molonc.2013.07.009
    By:
    • Grupp, Katharina;
    • Sanader, Stella;
    • Sirma, Hüseyin;
    • Simon, Ronald;
    • Koop, Christina;
    • Prien, Kristina;
    • Hube-Magg, Claudia;
    • Salomon, Georg;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Minner, Sarah;
    • Izbicki, Jakob R.;
    • Sauter, Guido;
    • Schlomm, Thorsten;
    • Tsourlakis, Maria Christina
    Publication type:
    Article
    8

    High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.

    Published in:
    2018
    By:
    • Heumann, Asmus;
    • Heinemann, Nina;
    • Hube-Magg, Claudia;
    • Lang, Dagmar S.;
    • Grupp, Katharina;
    • Kluth, Martina;
    • Minner, Sarah;
    • Möller-Koop, Christina;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Tsourlakis, Maria Christina;
    • Wilczak, Waldemar;
    • Wittmer, Corinna;
    • Jacobsen, Frank;
    • Huland, Hartwig;
    • Simon, Ronald;
    • Schlomm, Thorsten;
    • Sauter, Guido;
    • Steurer, Stefan;
    • Lebok, Patrick
    Publication type:
    journal article
    9
    10
    11

    Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2020, v. 477, n. 5, p. 625, doi. 10.1007/s00428-020-02834-4
    By:
    • Möller, Katharina;
    • Wecker, Anna Lena;
    • Höflmayer, Doris;
    • Fraune, Christoph;
    • Makrypidi-Fraune, Georgia;
    • Hube-Magg, Claudia;
    • Kluth, Martina;
    • Steurer, Stefan;
    • Clauditz, Till S.;
    • Wilczak, Waldemar;
    • Simon, Ronald;
    • Sauter, Guido;
    • Huland, Hartwig;
    • Heinzer, Hans;
    • Haese, Alexander;
    • Schlomm, Thorsten;
    • Weidemann, Sören;
    • Luebke, Andreas M.;
    • Minner, Sarah;
    • Bernreuther, Christian
    Publication type:
    Article
    12

    VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy.

    Published in:
    International Journal of Molecular Sciences, 2015, v. 16, n. 4, p. 8591, doi. 10.3390/ijms16048591
    By:
    • Tsourlakis, Maria Christina;
    • Khosrawi, Puya;
    • Weigand, Philipp;
    • Kluth, Martina;
    • Hube-Magg, Claudia;
    • Minner, Sarah;
    • Koop, Christina;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Wittmer, Corinna;
    • Sauter, Guido;
    • Krech, Till;
    • Wilczak, Waldemar Wilczak;
    • Huland, Hartwig;
    • Simon, Ronald;
    • Schlomm, Thorsten;
    • Steurer, Stefan
    Publication type:
    Article
    13

    Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions.

    Published in:
    Pathology & Oncology Research, 2020, v. 26, n. 4, p. 2709, doi. 10.1007/s12253-020-00861-9
    By:
    • Bernreuther, Christian;
    • Daghigh, Ferdous;
    • Möller, Katharina;
    • Hube-Magg, Claudia;
    • Lennartz, Maximilian;
    • Lutz, Florian;
    • Rico, Sebastian Dwertmann;
    • Fraune, Christoph;
    • Dum, David;
    • Luebke, Andreas M.;
    • Eichenauer, Till;
    • Möller-Koop, Christina;
    • Schlomm, Thorsten;
    • Wittmer, Corinna;
    • Huland, Hartwig;
    • Heinzer, Hans;
    • Graefen, Markus;
    • Haese, Alexander;
    • Burandt, Eike;
    • Tsourlakis, Maria Christina
    Publication type:
    Article
    14
    15
    16

    Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.

    Published in:
    BioMed Research International, 2020, p. 1, doi. 10.1155/2020/5845374
    By:
    • Kind, Simon;
    • Kluth, Martina;
    • Hube-Magg, Claudia;
    • Möller, Katharina;
    • Makrypidi-Fraune, Georgia;
    • Lutz, Florian;
    • Lennartz, Maximilian;
    • Rico, Sebastian Dwertmann;
    • Schlomm, Thorsten;
    • Heinzer, Hans;
    • Höflmayer, Doris;
    • Weidemann, Sören;
    • Uhlig, Ria;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Bernreuther, Christian;
    • Tsourlakis, Maria Christina;
    • Minner, Sarah;
    • Dum, David;
    • Hinsch, Andrea
    Publication type:
    Article
    17
    18
    19

    SNW1 is a prognostic biomarker in prostate cancer.

    Published in:
    Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0810-8
    By:
    • Höflmayer, Doris;
    • Willich, Carla;
    • Hube-Magg, Claudia;
    • Simon, Ronald;
    • Lang, Dagmar;
    • Neubauer, Emily;
    • Jacobsen, Frank;
    • Hinsch, Andrea;
    • Luebke, Andreas M.;
    • Tsourlakis, Marie Christina;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Minner, Sarah;
    • Büscheck, Franziska;
    • Sauter, Guido;
    • Schlomm, Thorsten;
    • Steurer, Stefan;
    • Clauditz, Till S.
    Publication type:
    Article
    20

    Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG‐negative prostate cancer.

    Published in:
    Prostate, 2020, v. 80, n. 13, p. 1097, doi. 10.1002/pros.24038
    By:
    • Bonk, Sarah;
    • Kluth, Martina;
    • Jansen, Kristina;
    • Hube‐Magg, Claudia;
    • Makrypidi‐Fraune, Georgia;
    • Höflmayer, Doris;
    • Weidemann, Sören;
    • Möller, Katharina;
    • Uhlig, Ria;
    • Büscheck, Franziska;
    • Luebke, Andreas M.;
    • Burandt, Eike;
    • Clauditz, Till S.;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Huland, Hartwig;
    • Heinzer, Hans;
    • Sauter, Guido;
    • Simon, Ronald;
    • Dum, David
    Publication type:
    Article
    21

    Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.

    Published in:
    Prostate, 2019, v. 79, n. 3, p. 302, doi. 10.1002/pros.23736
    By:
    • Minner, Sarah;
    • Lutz, Jannes;
    • Hube‐Magg, Claudia;
    • Kluth, Martina;
    • Simon, Ronald;
    • Höflmayer, Doris;
    • Burandt, Eike;
    • Tsourlakis, Maria Christina;
    • Sauter, Guido;
    • Büscheck, Franziska;
    • Wilczak, Waldemar;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Jacobsen, Frank;
    • Hinsch, Andrea;
    • Poos, Alexandra
    Publication type:
    Article
    22
    23

    Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.

    Published in:
    Prostate, 2016, v. 76, n. 3, p. 259, doi. 10.1002/pros.23120
    By:
    • Melling, Nathaniel;
    • Taskin, Berivan;
    • Hube‐Magg, Claudia;
    • Kluth, Martina;
    • Minner, Sarah;
    • Koop, Christina;
    • Grob, Tobias;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Tsourlakis, Maria Christina;
    • Izbicki, Jakob;
    • Wittmer, Corinna;
    • Huland, Hartwig;
    • Simon, Ronald;
    • Wilczak, Waldemar;
    • Sauter, Guido;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Krech, Till
    Publication type:
    Article
    24

    SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.

    Published in:
    Prostate, 2013, v. 73, n. 15, p. 1690, doi. 10.1002/pros.22707
    By:
    • Grupp, Katharina;
    • Diebel, Franz;
    • Sirma, Hüseyin;
    • Simon, Ronald;
    • Breitmeyer, Karin;
    • Steurer, Stefan;
    • Hube‐Magg, Claudia;
    • Prien, Kristina;
    • Pham, Taher;
    • Weigand, Philipp;
    • Michl, Uwe;
    • Heinzer, Hans;
    • Kluth, Martina;
    • Minner, Sarah;
    • Tsourlakis, Maria Christina;
    • Izbicki, Jakob R.;
    • Sauter, Guido;
    • Schlomm, Thorsten;
    • Wilczak, Waldemar
    Publication type:
    Article
    25

    High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.

    Published in:
    BJU International, 2017, v. 120, n. 3, p. 365, doi. 10.1111/bju.13840
    By:
    • Steurer, Stefan;
    • Rico, Sebastian Dwertmann;
    • Simon, Ronald;
    • Minner, Sarah;
    • Tsourlakis, Maria Christina;
    • Krech, Till;
    • Koop, Christina;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Adam, Meike;
    • Huland, Hartwig;
    • Schlomm, Thorsten;
    • Sauter, Guido;
    • Lumiani, Agron
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE ( AUO-AB 31/05).

    Published in:
    BJU International, 2014, v. 113, n. 3, p. 429, doi. 10.1111/bju.12437
    By:
    • Krege, Susanne;
    • Rexer, Heidrun;
    • Dorp, Frank;
    • Geeter, Patrick;
    • Klotz, Theodor;
    • Retz, Margitte;
    • Heidenreich, Axel;
    • Kühn, Michael;
    • Kamradt, Joern;
    • Feyerabend, Susan;
    • Wülfing, Christian;
    • Zastrow, Stefan;
    • Albers, Peter;
    • Hakenberg, Oliver;
    • Roigas, Jan;
    • Fenner, Martin;
    • Heinzer, Hans;
    • Schrader, Mark
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.

    Published in:
    BJU International, 2010, v. 105, n. 6, p. 818, doi. 10.1111/j.1464-410X.2009.08841.x
    By:
    • Isbarn, Hendrik;
    • Karakiewicz, Pierre I.;
    • Ahyai, Sascha A.;
    • Chun, Felix K.H.;
    • Jeldres, Claudio;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Zacharias, Mario;
    • Heuer, Roman;
    • Eichelberg, Christian;
    • Steuber, Thomas;
    • Budäus, Lars;
    • Köllermann, Jens;
    • Salomon, Georg;
    • Schlomm, Thorsten;
    • Perrotte, Paul;
    • Fisch, Margit;
    • Huland, Hartwig;
    • Graefen, Markus
    Publication type:
    Article
    38

    The presence of prostate cancer on saturation biopsy can be accurately predicted.

    Published in:
    BJU International, 2010, v. 105, n. 5, p. 636, doi. 10.1111/j.1464-410X.2009.08744.x
    By:
    • Ahyai, Sascha A.;
    • Isbarn, Hendrik;
    • Karakiewicz, Pierre I.;
    • Chun, Felix K.H.;
    • Reichert, Mathias;
    • Walz, Jochen;
    • Steuber, Thomas;
    • Jeldres, Claudio;
    • Schlomm, Thorsten;
    • Heinzer, Hans;
    • Salomon, Georg;
    • Budäus, Lars;
    • Perrotte, Paul;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander
    Publication type:
    Article
    39
    40
    41
    42

    Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?

    Published in:
    World Journal of Urology, 2023, v. 41, n. 2, p. 421, doi. 10.1007/s00345-023-04287-1
    By:
    • Mehring, Gisa;
    • Tilki, Derya;
    • Heinzer, Hans;
    • Steuber, Thomas;
    • Pose, Randi M.;
    • Thederan, Imke;
    • Budäus, Lars;
    • Salomon, Georg;
    • Haese, Alexander;
    • Michl, Uwe;
    • Maurer, Tobias;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Isbarn, Hendrik
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.

    Published in:
    Cancer Biology & Medicine, 2021, v. 18, n. 1, p. 245, doi. 10.20892/j.issn.2095-3941.2019.0324
    By:
    • Marx, Andreas;
    • Koopmann, Lena;
    • Höflmayer, Doris;
    • Büscheck, Franziska;
    • Hube-Magg, Claudia;
    • Steurer, Stefan;
    • Eichenauer, Till;
    • Clauditz, Till S.;
    • Wilczak, Waldemar;
    • Simon, Ronald;
    • Sauter, Guido;
    • Izbicki, Jakob R.;
    • Huland, Hartwig;
    • Heinzer, Hans;
    • Graefen, Markus;
    • Haese, Alexander;
    • Schlomm, Thorsten;
    • Bernreuther, Christian;
    • Lebok, Patrick;
    • Bonk, Sarah
    Publication type:
    Article
    50

    Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers.

    Published in:
    Cancer Biology & Medicine, 2019, v. 16, n. 2, p. 319, doi. 10.20892/j.issn.2095-3941.2018.0384
    By:
    • Luebke, Andreas M.;
    • Attarchi-Tehrani, Ali;
    • Meiners, Jan;
    • Hube-Magg, Claudia;
    • Lang, Dagmar S.;
    • Kluth, Martina;
    • Tsourlakis, Maria Christina;
    • Minner, Sarah;
    • Simon, Ronald;
    • Sauter, Guido;
    • Büscheck, Franziska;
    • Jacobsen, Frank;
    • Hinsch, Andrea;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Clauditz, Till S.
    Publication type:
    Article